Kristel Polder, MD
Dermatology · Dallas, TXNPI 1629234364
Payments from drug & device makers
Across 428 payments — averaging $1776.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580K
- Bausch Health US, LLC$167K
- Solta Medical, A Division Of Bausch Health US, LLC$10K
- Aclaris Therapeutics, Inc.$564
- Galderma Laboratories, L.p.$483
- Sun Pharmaceutical Industries Inc.$388
- plus $2K from 26 others
Across 6 payments — averaging $34.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$208
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 267 | $580,138 |
| Bausch Health US, LLC | 3 | $166,933 |
| Solta Medical, A Division Of Bausch Health US, LLC | 14 | $9,962 |
| Aclaris Therapeutics, Inc. | 7 | $564 |
| Galderma Laboratories, L.p. | 31 | $483 |
| Sun Pharmaceutical Industries Inc. | 17 | $388 |
| Lilly USA, LLC | 7 | $253 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $205 |
| Pfizer | 11 | $173 |
| Mayne Pharma Commercial LLC | 7 | $171 |
| EPI Health, LLC | 8 | $161 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $147 |
| LEO Pharma Inc. | 4 | $103 |
| Sanofi | 3 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Prugen, Inc. Pharmaceuticals | 1 | $71 |
| VYNE Pharmaceuticals Inc. | 4 | $69 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
| Novartis | 3 | $57 |
| Journey Medical Corporation | 3 | $57 |
| Merz North America, Inc. | 3 | $56 |
| Dermavant Sciences, Inc. | 3 | $55 |
| Botanix SB Inc | 2 | $43 |
| Almirall LLC | 2 | $43 |
| Glenmark Therapeutics Inc. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Bristol Myers Squibb | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$760,515 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Dallas
- Jennifer CatherDallas$4.9M
- Martin MenterDallas$3.7M
- So Yeon PaekDallas$3.5M
- Ross RaduskyDallas$3.3M
- Joseph MerolaDallas$2.1M
- William AbramovitsDallas$1.8M
- Donald GlassDallas$847K
- Mary HornerDallas$457K
- Gregory PetersonDallas$412K
- Kelly WarrenDallas$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.